Litigation Details for UCB, Inc. v. Mylan Technologies, Inc. (D. Vt. 2019)
✉ Email this page to a colleague
UCB, Inc. v. Mylan Technologies, Inc. (D. Vt. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-07-16 |
Court | District Court, D. Vermont | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Christina R |
Jury Demand | Referred To | ||
Patents | 10,130,589; 10,350,174; 10,383,853; 6,805,383; 7,785,779; 7,856,779; 8,158,853; 8,785,415; 8,853,156; 8,925,726; 9,726,669; 9,925,150; 9,925,156; 9,925,158; 9,925,174 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in UCB, Inc. v. Mylan Technologies, Inc.
Biologic Drugs cited in UCB, Inc. v. Mylan Technologies, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for UCB, Inc. v. Mylan Technologies, Inc. (D. Vt. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-05-08 | 95 | Order re: Claim Construction Brief | infringed two patents, United States patent No. 10,130,589 B2 (the "'589 patent") and United…States patent No. 10,350,174 B2 (the "' 174 patent") (collectively, the "patents-in-suit…both continuations of the same parent patent, United States patent No. 9,925,150, and have the same specifications…#39;5 89 patent and "[a] stable solid dispersion" in claim 1 of the ' 174 patent. II. …quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |